Carrie Smith Cox
Executive Chair of the BoardMs. Carrie Smith Cox had been an Independent Chairman of the Board at Organon & Co. since June 2, 2021 until October, 2025 and served as its Interim Executive Chairman of the Board from October, 2025 until 2025 and serves as its Executive Chair of the Board since 2025. She served as an Independent Chairman of the Board of Cartesian Therapeutics, Inc. from November 2019 until October 29, 2025. She served as Special Advisor to the CEO at Candel Therapeutics, Inc. since July 15, 2021. She served as Chairman of the Board at Candel Therapeutics, Inc. (formerly known as Advantagene, Inc.) since May 2021 until July 15, 2021. She was an Independent Chairman and Director of Selecta Biosciences, Inc. since November 2019. She served as Chairman at Array BioPharma Inc. since August 9, 2018 until July 30, 2019. Ms. Cox served as the Executive Chairman of Humacyte, Inc. since 2013 until 2019 and previously she was Chief Executive Officer at Humacyte, Inc. since September 20, 2010 until June 2018. Ms. Cox served as an Executive Vice President and President of Global Pharmaceutical Business at Schering-Plough Corporation from May 15, 2003 to November 3, 2009, where she was responsible for its global prescription pharmaceutical business. She joined Humacyte, Inc., in 2010. Ms. Cox was Schering-Plough's executive sponsor for the Merck/Schering-Plough Cholesterol Joint Venture (the "Joint Venture"). She served as President of Global Pharmaceuticals and Executive Vice President at Merck & Co., Inc. Ms. Cox joined Schering-Plough in May 2003. She was responsible for leading the transformation of the Global Pharmaceutical Business into a profitable, high-performing organization. She served as an Executive Vice President and President of Global Prescription Business at Pharmacia LLC from February 2001 to 2003. She served as an Executive Vice President and Head of Global Business Management at Pharmacia & Upjohn LLC from 1997 to March 2000. Prior to joining Schering-Plough, Ms. Cox served as President of Pharmacia Corporation’s global pharmaceutical business from 1997 until its merger with Pfizer Inc., in 2003. She was Senior Vice President of Global Business Management at Pharmacia & Upjohn. She joined U.K.-based Pharmacia and Upjohn (Pharmacia's predecessor company) in 1997 as a Senior Vice President. Prior to 1997, she served as Vice President, Women's Health Care of Wyeth-Ayerst Laboratories, a division of Wyeth until August 1997. She joined Pharmacia's predecessor company, Pharmacia & Upjohn, in 1997 as a Member of Top Management and was a strong contributor to Pharmacia & Upjohn's dramatic turnaround. She served as the Chairman of Prism Pharmaceuticals, Inc., since January 11, 2011. She is Retired Senior Vice President, U.S. Operations, United Parcel Service, Inc. She held a variety of positions in market research, sales and product management during her career with Sandoz Pharmaceuticals (now Novartis). Ms. Cox has been an Independent Director of Texas Instruments Inc. since September 16, 2004 and previously served as its Lead Director. She has been a Director of Celgene Limited since December 2009. She served as Director of electroCore, Inc. since June 2018 until March 31, 2020 and served as its Chairman of the Board since 2018 until March 31, 2020. She had been an Independent Director at Cardinal Health, Inc. since December 2009 until November 2023 and was an Independent Director of Celgene Corporation since December 16, 2009 until November 15, 2019. She served as a Director of Humacyte, Inc. until 2019. She served as a Director of Lyris, Inc. since September 16, 2004. Ms. Cox is a Member of the Harvard School of Public Health's Health Policy and Management Executive Council and is a Member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology. She was named six times to Fortune magazine's list of the 50 Most Powerful Women in Business. Her work has been featured in Harvard Business Review and in the New York Times bestseller, The Profit Zone. Ms. Cox is a registered Pharmacist and earned a Bachelor's of Science Degree in 1981 from the Massachusetts College of Pharmacy and Health Sciences.
Positions
- Company NameOrganon & Co.Stock CodeOGNPositionExecutive Chair of the BoardColleagues
- JTJoseph T. MorrisseyChief Executive Officer
- MMMatthew M. WalshExecutive VP & CFO
- RARachel A. StahlerExecutive VP, Chief Information Officer and Chief Digital & Growth Officer
- KWKirke WeaverExecutive VP, General Counsel & Corporate Secretary
- SSShalini SharpIndependent Director
- RARobert Alan EssnerLead Independent Director
- RAR. Alan B. EzekowitzIndependent Director
- HDHelene D. GayleIndependent Director
- Company NameSolventum CorporationStock CodeSOLVPositionIndependent ChairmanColleagues
- BCBryan C. HansonCEO & Director
- CSCarrie Smith CoxIndependent Chairman
- WDWayde D. McMillanExecutive VP & CFO
- ALAmy LanducciChief Information & Digital Officer
- MAMarcela A. KirbergerChief Corporate & Legal Affairs Officer & Corporate Secretary
- HLHeather L. KnightChief Commercial Officer
- SDSusan Dodson DeVoreIndependent Director
- GAGlenn Andrew EisenbergIndependent Director
- SAShirley Ann EdwardsIndependent Director
